tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

HLS Therapeutics Schedules Q2 Financial Results Call

Story Highlights
HLS Therapeutics Schedules Q2 Financial Results Call

HLS Therapeutics Inc (TSE:HLS) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

HLS Therapeutics Inc. is set to announce its second-quarter financial results for fiscal year 2024 on August 8, with a conference call scheduled for that morning hosted by CEO Craig Millian and Interim CFO John Hanna. The company specializes in acquiring and commercializing pharmaceuticals in North America, focusing on treatments for psychiatric disorders and cardiovascular disease.

For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1